Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: BMS, Catalyst, Chiasma, CNS, Cullinan, Gilead, Hansa, Medexus, Mediwound, Merck, Moderna, Neurogene, Orchard, Palatin, Prilenia, Rafael, Tracon, Vico, Yiling.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abcuro, Aditum, Ancora, Alligator, Alpine, Athersys, Bioaegis, Biogen, Cenexi, Clover, Cytovation, Dynavax, Elevation, Enochian, Genomic Testing Cooperative, Glaxosmithkline, ICER, Imaginab, Merck & Co., Nimble, Olimmune, Ose, Rayzebio, Scandion, Scopus, Siga, Taisho, Vir.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Addex, Astrazeneca, Brim, Celularity, Cerevel, Ciclomed, Compass Pathways, Elicio, F-star, Harmony, Horizon, Iovance, Moderna, Orchard, Pfizer, Propella, Synthetic Biologics, Trillium, VBI.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advanced Accelerator Applications, Avacta, Avicenna.AI, B. Braun, Bioivt, Cancer Targeted Technology, Cognetivity Neurosciences, Ethicon, Medline Industries, Merck, Neuroloop, Novacyt, Nuance, Orthofix Medical, Qiagen, Teleflex, Valley Biomedical Products & Services, Verogen.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abiomed, Attana, Front Line Medical, Galderma, Neuros Medical.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Agios, Asklepios, Astrazeneca, Atsena, Biomarin, Biontech, Braeburn, Camurus, Catalyst, Cend, Chugai, Genentech, Immunicum, Innocare, Innovent, Junshi, Kymera, Moderna, Oric, Pfizer, Regeneron, Roche, Rockwell, Saniona, Sanofi, Syndax, Zentalis.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acrivon, Amgen, Antios, Applied Biomath, APR, Arbutus, Astrazeneca, Baymedica, Brigham and Women's Hospital, Cannex, Carmot, Cell and Gene Therapy Catapult, Compugen, Curie Institute, Defence, Diurnal, Elevatebio, E r-Kim, Etherna, Ichnos, Inmed, Innovent, Ixaka, KBI, Lilly, Mosaic Biosciences, Mosaic Immunoengineering, Ocular, Paratek, PYC, Q-State, Quantoom, Relief, Selexis, Simcere, Somalogic, Synaffix, Vivoryon.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Achieve, Clovis, Dare, Hoth, Ideaya, Intellia, Kymera, Maat, Neurophth, Onconova, Pinteon, Precision Biosciences, Regenerative Patch, Regeneron, RDIF, Rigel, Sab, Sanofi, Springworks, Zentalis.